183 related articles for article (PubMed ID: 11026634)
1. Perivascular graft heparin delivery using biodegradable polymer wraps.
Edelman ER; Nathan A; Katada M; Gates J; Karnovsky MJ
Biomaterials; 2000 Nov; 21(22):2279-86. PubMed ID: 11026634
[TBL] [Abstract][Full Text] [Related]
2. Sustained release of heparin from polymeric particles for inhibition of human vascular smooth muscle cell proliferation.
Yang Z; Birkenhauer P; Julmy F; Chickering D; Ranieri JP; Merkle HP; Lüscher TF; Gander B
J Control Release; 1999 Aug; 60(2-3):269-77. PubMed ID: 10425332
[TBL] [Abstract][Full Text] [Related]
3. Effect of controlled adventitial heparin delivery on smooth muscle cell proliferation following endothelial injury.
Edelman ER; Adams DH; Karnovsky MJ
Proc Natl Acad Sci U S A; 1990 May; 87(10):3773-7. PubMed ID: 2339120
[TBL] [Abstract][Full Text] [Related]
4. Intramural injection of biodegradable microspheres as a local drug-delivery system to inhibit neointimal thickening in a rabbit model of balloon angioplasty.
Valéro F; Hamon M; Fournier C; Meurice T; Flautre B; Van Belle E; Lablanche JM; Gosselin B; Bauters C; Bertrand M
J Cardiovasc Pharmacol; 1998 Apr; 31(4):513-9. PubMed ID: 9554798
[TBL] [Abstract][Full Text] [Related]
5. Heparin/heparan sulfate chelation inhibits control of vascular repair by tissue-engineered endothelial cells.
Han RO; Ettenson DS; Koo EW; Edelman ER
Am J Physiol; 1997 Dec; 273(6):H2586-95. PubMed ID: 9435591
[TBL] [Abstract][Full Text] [Related]
6. Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rat model of arterial injury.
Wu B; Mottola G; Chatterjee A; Lance KD; Chen M; Siguenza IO; Desai TA; Conte MS
J Vasc Surg; 2017 Jan; 65(1):207-217.e3. PubMed ID: 27034112
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene inhibits vascular smooth muscle cell proliferation and neointima formation following balloon angioplasty of the rat carotid artery.
Chang MW; Ohno T; Gordon D; Lu MM; Nabel GJ; Nabel EG; Leiden JM
Mol Med; 1995 Jan; 1(2):172-81. PubMed ID: 8529096
[TBL] [Abstract][Full Text] [Related]
8. Polymeric-based perivascular delivery of a nitric oxide donor inhibits intimal thickening after balloon denudation arterial injury: role of nuclear factor-kappaB.
Kaul S; Cercek B; Rengstrom J; Xu XP; Molloy MD; Dimayuga P; Parikh AK; Fishbein MC; Nilsson J; Rajavashisth TB; Shah PK
J Am Coll Cardiol; 2000 Feb; 35(2):493-501. PubMed ID: 10676700
[TBL] [Abstract][Full Text] [Related]
9. Controlled delivery of therapeutics from microporous membranes. II. In vitro degradation and release of heparin-loaded poly(D,L-lactide-co-glycolide).
Kreitz MR; Domm JA; Mathiowitz E
Biomaterials; 1997 Dec; 18(24):1645-51. PubMed ID: 9613812
[TBL] [Abstract][Full Text] [Related]
10. Controlled delivery of the anti-VEGF aptamer EYE001 with poly(lactic-co-glycolic)acid microspheres.
Carrasquillo KG; Ricker JA; Rigas IK; Miller JW; Gragoudas ES; Adamis AP
Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):290-9. PubMed ID: 12506087
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of experimental neointimal hyperplasia and thrombosis depends on the type of vascular injury and the site of drug administration.
Rogers C; Karnovsky MJ; Edelman ER
Circulation; 1993 Sep; 88(3):1215-21. PubMed ID: 8353883
[TBL] [Abstract][Full Text] [Related]
12. Localized delivery of heparin to angioplasty sites with iontophoresis.
Mitchel JF; Azrin MA; Fram DB; Bow LM; McKay RG
Cathet Cardiovasc Diagn; 1997 Jul; 41(3):315-23. PubMed ID: 9213031
[TBL] [Abstract][Full Text] [Related]
13. Development of poly-(D,L-lactide--coglycolide) microsphere formulations containing recombinant human vascular endothelial growth factor to promote local angiogenesis.
Cleland JL; Duenas ET; Park A; Daugherty A; Kahn J; Kowalski J; Cuthbertson A
J Control Release; 2001 May; 72(1-3):13-24. PubMed ID: 11389981
[TBL] [Abstract][Full Text] [Related]
14. Perivascular delivery of heparin for the reduction of smooth muscle cell proliferation after endothelial injury.
Teomim D; Fishbien I; Golomb G; Orloff L; Mayberg M; Domb AJ
J Control Release; 1999 Jun; 60(1):129-42. PubMed ID: 10370177
[TBL] [Abstract][Full Text] [Related]
15. Regulation of smooth muscle cell proliferation using paclitaxel-loaded poly(ethylene oxide)-poly(lactide/glycolide) nanospheres.
Suh H; Jeong B; Rathi R; Kim SW
J Biomed Mater Res; 1998 Nov; 42(2):331-8. PubMed ID: 9773830
[TBL] [Abstract][Full Text] [Related]
16. The biologic effects of growth factor-toxin conjugates in models of vascular injury depend on dose, mode of delivery, and animal species.
Yu C; Cunningham M; Rogers C; Dinbergs ID; Edelman ER
J Pharm Sci; 1998 Nov; 87(11):1300-4. PubMed ID: 9811480
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid oligomers: Part II. Biodegradation and drug delivery application.
Wang N; Wu XS
J Biomater Sci Polym Ed; 1997; 9(1):75-87. PubMed ID: 9505204
[TBL] [Abstract][Full Text] [Related]
18. Site-specific administration of antisense oligonucleotides using biodegradable polymer microspheres provides sustained delivery and improved subcellular biodistribution in the neostriatum of the rat brain.
Khan A; Sommer W; Fuxe K; Akhtar S
J Drug Target; 2000; 8(5):319-34. PubMed ID: 11328659
[TBL] [Abstract][Full Text] [Related]
19. Encapsulation and stabilization of nerve growth factor into poly(lactic-co-glycolic) acid microspheres.
Lam XM; Duenas ET; Cleland JL
J Pharm Sci; 2001 Sep; 90(9):1356-65. PubMed ID: 11745788
[TBL] [Abstract][Full Text] [Related]
20. The fate of biodegradable microspheres injected into rat brain.
Nicholas AP; McInnis C; Gupta KB; Snow WW; Love DF; Mason DW; Ferrell TM; Staas JK; Tice TR
Neurosci Lett; 2002 Apr; 323(2):85-8. PubMed ID: 11950499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
